Agilent Technologies (A) Stock
Key stats
- Market cap
- $48.43B
- Price / Earnings ratio
- 34.7x
- EPS (TTM)
- $5.10
- Volume
- Loading
- 52-week high
- $182.99
- 52-week low
- $108.35
- Dividend yield
- 0.59%
- Dividend amount (latest)
- $0.26
- EPS vs analyst estimate
- 0.0%Q4 FY25 · $1.59 vs $1.59
Source: third-party data provider, as of November 7, 2026
EPS estimate: analyst consensus
Compare with A
Recent news

Agilent Launches 5987A MSD with GC Assist for Faster, Smarter GC/MS Workflows
Agilent Launches 5987A MSD with GC Assist for Faster, Smarter GC/MS Workflows
A

Agilent to Announce Fourth-Quarter Fiscal Year 2026 Financial Results on Nov. 23
Agilent to Announce Fourth-Quarter Fiscal Year 2026 Financial Results on Nov. 23
A

Agilent and University of Chicago Launch Center of Excellence for Energy Materials Research
Agilent and University of Chicago Launch Center of Excellence for Energy Materials Research
A

Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
A
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 49.44
- MACD 12/26/9
- 2.52
- EMA 9 of MACD
- 3.41
- MACD histogram
- -0.90
- SMA 50
- $165.57
- Price above SMA 50
- EMA 50
- $166.36
- Price above EMA 50
- SMA 200
- $136.74
- Price above SMA 200
- EMA 200
- $145.50
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 5, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 13 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $1.48 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Agilent Launches 5987A MSD with GC Assist for Faster, Smarter GC/MS Workflows
Agilent Launches 5987A MSD with GC Assist for Faster, Smarter GC/MS Workflows
A

Agilent to Announce Fourth-Quarter Fiscal Year 2026 Financial Results on Nov. 23
Agilent to Announce Fourth-Quarter Fiscal Year 2026 Financial Results on Nov. 23
A

Agilent and University of Chicago Launch Center of Excellence for Energy Materials Research
Agilent and University of Chicago Launch Center of Excellence for Energy Materials Research
A

Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
A

Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?
Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?
A

Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows
Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows
A

Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers
Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers
A

Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue?
Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue?
A

Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation
Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation
A

Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control
A
News tone: automated (AI) classification of the article's content, not a price prediction.
About Agilent Technologies
Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Padraig McDonnell | CEO, President & Director | 1972 |
| Mr. Adam S. Elinoff | Senior VP, CFO & Principal Financial Officer | 1978 |
| Mr. Rodney Gonsalves | Vice President of Finance | 1966 |
| Ms. Angelica A. Riemann | Senior VP & President of Agilent CrossLab Group | 1971 |
| Dr. Simon May | Senior VP and President of Life Sciences & Diagnostics Markets Group | 1973 |
| Mr. Bret M. DiMarco | Special Advisor | 1968 |
| Mr. Tim Downs | VP & Chief Accounting Officer | 1981 |
| Mr. August Specht Ph.D. | Senior VP & Chief Technology Officer | — |
| Mr. Tejas Rajeev Savant | Vice President of Investor Relations | — |
| Mr. Michael Buckner | Senior VP, Chief Legal Officer & Secretary | — |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 7, 2026
Technical indicators
- RSI 14
- 49.44
- MACD 12/26/9
- 2.52
- EMA 9 of MACD
- 3.41
- MACD histogram
- -0.90
- SMA 50
- $165.57
- Price above SMA 50
- EMA 50
- $166.36
- Price above EMA 50
- SMA 200
- $136.74
- Price above SMA 200
- EMA 200
- $145.50
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 5, 2026. Technical data, not a recommendation.
Analyst views
13 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $172.00
- Average
- $184.85
- High
- $196.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -6.2 | +7.7 | ||||||||||
| 2022 | -11.0 | -7.6 | +0.3 | -11.0 | +6.7 | -3.5 | +12.5 | -3.9 | -5.7 | +9.5 | +10.0 | -4.1 |
| 2023 | +1.4 | -8.7 | +0.6 | -1.8 | -15.0 | +3.4 | +2.1 | -1.2 | -8.3 | -6.8 | +24.2 | +8.0 |
| 2024 | -6.2 | +3.2 | +4.6 | -5.9 | -6.0 | -1.3 | +11.0 | +0.0 | +6.9 | -11.1 | +0.8 | -3.8 |
| 2025 | +13.6 | -13.9 | -7.4 | -5.7 | +5.1 | +6.3 | -4.7 | +10.7 | +2.5 | +5.6 | +6.1 | -9.3 |
| 2026 | -3.0 | -10.3 | -3.5 | +0.9 | +18.3 | -2.3 | +3.7 | +9.8 | +14.9 | +4.9 | -0.1 |
Corporate actions
Upcoming
No upcoming corporate actions for A



